RMIT scientists in Melbourne have led an international collaboration that potentially unlocks better treatment of viral diseases, including the flu and common cold.
The results were published in the prestigious scientific and medical journal Nature Communications.
Each year the flu virus sends 13,500 Australians to hospital and causes more than 3000 deaths among those aged over 50. The global burden is also staggering, with more than 5 million cases of infection annually with up to 10 per cent resulting in death.
The RMIT senior authors, Dr Stavros Selemidis (ARC Future Fellow) and Dr Eunice To (first author), collaborated with Professor Doug Brooks from University South Australia, Professor John O’Leary from Trinity College Dublin, Monash University’s Professor Christopher Porter, and other scientists and clinicians to investigate how viruses cause disease in humans.
The researchers discovered that a 1.5 billion-year-old cell biological process found in plants, fungi and mammals enhances viral disease in mice and highly likely also in humans. They identified a protein, Nox2 oxidase, that is activated by viruses, including influenza, rhinovirus (the common cold), dengue and HIV.
Once activated, Nox2 oxidase suppresses the body’s key antiviral reaction and its ability to fight and clear the viral infection, which in turn results in a stronger or more virulent disease in mice.
The study also investigated a new prototype drug to treat these debilitating viral diseases.
The researchers found that the Nox2 oxidase protein activated by the viruses is located in a cell compartment called endosomes. They carefully modified a chemical that inhibits or restrains the activity of Nox2 oxidase.
Their customised drug was found to be very effective at suppressing disease caused by influenza infection.
Selemidis, head of the Oxidant and Inflammation Biology Group within the Chronic Infectious and Inflammatory Diseases program at RMIT, said: “Current treatment strategies are limited as they specifically target circulating viruses and have either unknown or very little effect against new viruses that enter the human population.
“We have identified a protein of the immune system that contributes to the disease caused by flu viruses irrespective of their strain.
“We also developed a novel drug delivery system to target this protein, which drastically alleviated the burden of viral disease.
“The strength of this work is the multidisciplinary approach taken and the degree of collaboration. It includes researchers and clinicians from eight universities across Australia, the United States and Ireland.
“This work attracted considerable interest at the NADPH Oxidase GORDON conference in the USA last year.”
To said: “This work identifies a treatment strategy that has the potential to alleviate the symptoms caused by some of the most devastating viruses worldwide, including the flu.”
The Latest on: Viral diseases
- China Cuts Australian Beef Imports After Warning Over Virus Probeon May 12, 2020 at 12:39 am
China suspended imports from four major Australian beef suppliers Tuesday, just weeks after Beijing's ambassador warned of a consumer boycott in retaliation for Canberra's push to probe the origins of ...
- Doctors and nurses died as Iran ignored virus concernson May 12, 2020 at 12:00 am
They are regarded as heroes, their fallen colleagues as martyrs. But for doctors and nurses still dealing with Iran’s growing number of coronavirus infections, such praise rings ...
- Virus Hope In US As WHO Hails Global Progresson May 11, 2020 at 11:58 pm
The United States logged a second consecutive day of fewer than 900 coronavirus deaths, as the World Health Organization hailed global progress but warned of the need for "extreme vigilance" against a ...
- Global Virus Updates: Expert Warns Many Countries Are Driving Blind as They Reopenon May 11, 2020 at 11:57 pm
India’s trains will start rolling again and millions in the Philippines will be able to leave their homes, even as a top health official warns that many countries are driving blind as they reopen ...
- Inflammatory, virus-related disease linked to children up to 93 cases statewideon May 11, 2020 at 2:32 pm
Two to three children are coming into one Long Island hospital daily with an inflammatory disease thought to be tied to COVID-19, health care officials said Monday. Most of these young patients are so ...
- Road Salt Might Make Frogs More Vulnerable To Diseaseon May 11, 2020 at 1:04 pm
Scientists at Washington State University surveyed 18 ponds with similar populations of wood frogs tadpoles during summer months when Ranavirus, a disease that kills amphibians and reptiles in North ...
- Disease experts declare it’s time to join forces for multiple COVID-19 vaccineson May 11, 2020 at 11:02 am
Unprecedented collaborations involving the biotech industry and government agencies are urgently needed to develop and produce the billions of doses of vaccine that will be needed to stop the ...
- We need a national reopening plan, not a state-by-state experiment: Infectious disease specialiston May 11, 2020 at 10:57 am
A recent resurgence of COVID-19 cases in South Korea has raised questions of whether or not the easing of social distancing in the U.S. will lead to a similar outcome. Associate Dean for Global Health ...
- Boston infectious disease experts: Don’t reopen Massachusetts too quicklyon May 11, 2020 at 10:11 am
The coronavirus crisis is not over. Discussions of reopening should, by necessity, be part of a unified strategy that also includes plans to reclose.
- Increasing Prevalence of Infectious Diseases Driving Growth in the Global Hazmat Suits Market - ResearchAndMarkets.comon May 11, 2020 at 8:42 am
The "Global Hazmat Suits Market 2020-2024" report has been added to ResearchAndMarkets.com's offering. The hazmat suits market is poised to grow by $ 3.83 billion during 2020-2024 progressing at a ...
via Google News and Bing News